ATRA · Atara Biotherapeutics, Inc.
$8.09
-0.42 (-4.94%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we have concluded that substantial doubt exists with respect to our ability to continue as a going concern for at least 12 months after the issuance of the accompanying condensed consolidated financial statements.”View the 10-Q filed Aug 12, 2026
Market Cap
$81.21M
Shares
10.04M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-09 | Annual Meeting of Stockholders | Shareholder meeting |
Source: https://investors.atarabio.com/
Key facts
CIK
1604464
CUSIP
046513206
13F (30d)
38 filings
36 filers
Visit website
Investor relations